CG Oncology Stock Quote CGON - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

34.80

Bid

34.80

Ask

39.19

Volume

1,193,827

34.77 Day's Range 36.63

25.77 52 Week Range 50.23

Market Cap

1.682B

Previous Close

34.83

Open

35.24

Last Trade

34.8

Last Trade Time

16:20:00

Financial Volume

$ 43,058,009

VWAP

36.0672

Average Volume (3m)

621,858

Shares Outstanding

48,330,000

Dividend Yield

PE Ratio

-24.80

Earnings Per Share (EPS)

-1.4

Revenue

204k

Net Profit

-67.8M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

cgoncology.com

Headquarters

Dover, Delaware, USA

Founded

CG Oncology Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CGON. The last closing price for CG Oncology was $34.83. Over the last year, CG Oncology shares have traded in a share price range of $ 25.77 to $ 50.23.

CG Oncology currently has 48,330,000 shares outstanding. The market capitalization of CG Oncology is $1.68 billion. CG Oncology has a price to earnings ratio (PE ratio) of -24.80.

Form 4 - Statement of changes in beneficial ownership of securities

CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

IRVINE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

Form 144 - Report of proposed sale of securities

CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates

– Final positive safety and efficacy findings from CORE-001 study of Cretostimogene Grenadenorepvec in combination with Pembrolizumab in BCG-Unresponsive NMIBC simultaneously published online...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

CG Oncology Initiates Expanded Access Program for Cretostimogene Grenadenorepvec

IRVINE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBC

– Final positive CORE-001 safety and efficacy findings were published simultaneously online by Nature Medicine and featured at ASCO 2024 – – 54% complete response (CR) rate in the...

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.54	1.5761821366	34.26	40.2	33.77	534126	36.57163262	CS
4	2.69	8.37745250701	32.11	40.2	29	559875	34.2589688	CS
12	-0.89	-2.49369571308	35.69	46.99	25.77	621858	34.9492178	CS
26	5.8	20	29	50.23	25.77	648524	35.98123634	CS
52	5.8	20	29	50.23	25.77	648524	35.98123634	CS
156	5.8	20	29	50.23	25.77	648524	35.98123634	CS
260	0	0	0	40.2	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
XCURExicure Inc	$ 2.85 (78.13%)	3.27M
ZVSAZyVersa Therapeutics Inc	$ 2.75 (26.15%)	81.85k
BBLGBone Biologics Corporation	$ 0.98 (22.50%)	331.46k
CJETChijet Motor Company Inc	$ 4.05 (19.47%)	1.68M
CURRCurrenc Group Inc	$ 2.88 (15.20%)	44.76k
GNTAGenenta Science SPA	$ 2.20 (-44.30%)	303
PTIXProtagenic Therapeutics Inc	$ 0.69 (-12.66%)	84.62k
TBIOTelesis Bio Inc	$ 1.41 (-11.88%)	1.29k
WLGSWang and Lee Group Inc	$ 1.24 (-10.79%)	2.58k
WPRTWestport Fuel Systems Inc	$ 4.80 (-9.43%)	18.57k
LDTCLeddarTech Holdings Inc	$ 0.444 (0.52%)	4.04M
MULNMullen Automotive Inc	$ 0.1305 (-1.29%)	3.41M
XCURExicure Inc	$ 2.85 (78.13%)	3.27M
NVDANVIDIA Corporation	$ 118.8707 (-0.19%)	2.37M
XXII22nd Century Group Inc	$ 0.361 (5.49%)	2.29M